细胞培养蛋白表面涂层市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

细胞培养蛋白表面涂层市场预计在预测期内的复合年增长率为 9.5%。

当 COVID-19 首次出现时，许多生物技术和製药公司、各国政府和研究机构都致力于开发高效疫苗和新疗法来治疗该问题。 细胞培养促进了用于治疗 COVID-19 的新疫苗的研製。

主要亮点

• 2022 年 7 月发表在《临床病毒学杂誌》上的一篇报告发现，在培养物中分离出 SARS-CoV-2 的概率、出现症状的天数较少和较低的 RT-PCR 循环阈值之间存在显着的正相关。 因此，在 COVID-19 期间，细胞培养被用于正确诊断，这有望促进细胞培养蛋白表面涂层市场的增长。 对该病毒的研究仍在进行中，因此预计它将在未来产生重大影响。
• 干细胞研究活动的增加、对蛋白质治疗和靶向治疗的需求增加以及对 3D 细胞培养的偏好超过 2D 细胞培养等主要因素正在推动预测期内的市场增长。它是。
• 优化细胞培养环境可让细胞以真实且具有代表性的方式生长、发挥功能和存活。 细胞培养表面的蛋白质涂层用细胞外基质或蛋白质成分包裹细胞培养表面，以增强细胞在体外的生长和粘附。 预计干细胞研究活动的增加将对市场增长产生积极影响。
• 例如，2022 年 6 月，哈佛干细胞研究所 (HSCI) 开始为其 2022 年周期征集种子资金。 该计划的目的是资助干细胞和再生生物学领域的创造性工作，以加速新的基于干细胞的治疗和疗法的开发。 根据上述消息来源，赠款金额为每个项目每年 100,000 美元，最多两年。 因此，研究资金可能会在预测期内促进干细胞研究活动并推动市场增长。
• 但是，细胞培养蛋白表麵包被产品的高成本以及动物源性蛋白包被材料的使用限制可能会阻碍市场增长。

细胞培养蛋白表面涂层的市场趋势

预测期内预涂微孔板有望增长

• 微孔板也称为微孔板或微量滴定板或多孔板。 微孔板已成为分析研究和临床诊断实验室的标准工具。 根据细胞类型、传代、来源和细胞培养基的组成，培养中的细胞以不同的方式粘附在培养板上，即使是在专门为细胞培养製造的塑料上生长也是如此。
• 在研究期间，在微孔板中，新的进展、批准和发布正在推动市场增长。 例如，2022 年 4 月，Porvair Sciences Sero Krystal PDL 系列涂层微孔板将为可重现的细胞培养设立新标准，即使是困难的细胞类型。
• 市场上先进的□标仪正在增加微孔板在生物技术中的使用，从而推动市场发展。 例如，2022 年 4 月，Molecular Devices LLC 宣布推出 SpectraMax mini 多模式□标仪，这是一种紧凑且经济的解决方案，旨在节省研究人员的工作台空间和预算。 同样，2022 年 2 月，BMG LABTECH 将推出 VANTAstar □标仪，进一步扩大其高品质德国製造仪器的范围。 VANTAstar 是一款紧凑型多模式□标仪，具有三个功能，可轻鬆进行检测设置并提高数据质量。
• 因此，此类进步和发布预计将通过该细分市场对市场产生重大影响。

据估计北美占据最大的市场份额

• 北美以资助细胞培养实验室和医疗保健研究而闻名。 预计在预测期内它将主导市场。 在美国，国立卫生研究院 (NIH) 每年都为干细胞研究提供大量资金。 为了研究癌症疾病和个性化医疗，美国国家癌症研究所 (NCI) 向与大学和研究机构合作的公司分配了大量资金。
• 美国癌症协会预测，2022 年美国将新增 1,918,030 例癌症病例。 预计癌症患者的增加将在预测期内对市场产生重大影响，因为它增加了对涉及细胞培养的靶向治疗的需求。 此外，2022 年 2 月，KromaTiD 推出了一套全面的细胞和血培养扩展、分离、处理和质量控制服务。 这些因素推动了细胞培养活动的重要性。
• 此外，市场主要参与者的扩张也会对市场产生重大影响。 例如，2021 年 7 月，全球生命科学试剂和工具的创新者 Abcam 在美国马萨诸塞州沃尔瑟姆开设了一家大型新工厂。 新设施是 Abcam 在美国发展的核心组成部分，并加强了其支持研究和生物製药行业的承诺。
• 因此，由于上述因素，预计北美地区的研究市场在预测期内将出现大幅增长。

细胞培养蛋白表面涂层市场竞争分析

细胞培养蛋白表面涂层市场较为分散，由几家主要参与者组成。 主要市场参与者正专注于蛋白质技术和细胞培养技术的技术进步。 市场上的主要参与者包括 Abcam PLC、Corning Incorporated、Greiner AG（Greiner Bio-One International GmbH）、Merck KGaA、Promega Corporation、Sartorius AG、Qiagen NV、Viogene、Thermo Fisher Scientific Inc。

其他好处

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 研究假设和市场定义
• 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动力
  • 启动干细胞研究
  • 对蛋白质疗法和靶向疗法的需求不断增长
  • 越来越喜欢从 2D 细胞培养到 3D 细胞培养
• 市场製约因素
  • 用于细胞培养的蛋白质表麵包被产品成本高
  • 限制使用动物来源的蛋白质涂层材料
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

• 按蛋白质来源
  • 动物来源的蛋白质
  • 人源蛋白
  • 合成蛋白质
  • 植物来源的蛋白质
• 按涂层类型
  • 自涂层
  • 预涂
    • 微孔板
    • 培养皿
    • 烧瓶
    • 幻灯片
    • 其他预涂剂
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • Abcam PLC
  • Corning Incorporated
  • Greiner AG（Greiner Bio-One International GmbH）
  • Merck KGaA
  • Promega Corporation
  • Qiagen NV
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Viogene

第7章 市场机会与今后动向

The cell culture protein surface coatings market is expected to register a CAGR of 9.5% over the forecast period. When COVID-19 first appeared, a lot of biotech and pharmaceutical companies, governments from different nations, and research institutions began to concentrate on the creation of efficient vaccines and novel treatments to treat the problem. The creation of new vaccines for the treatment of COVID-19 was facilitated by cell culture.

Key Highlights

• As per the report published by the Journal of Clinical Virology in July 2022, there was a significant positive correlation between the probability of isolating SARS-CoV-2 in culture, fewer days of symptoms, and a lower RT-PCR cycle threshold value. Hence the cell culture was used during COVID-19 for proper diagnosis and was expected to grow the cell culture protein surface coatings market. As viral studies are still ongoing, it is expected to have a significant impact in the coming future.
• The major factors, such as increasing stem cell research activities, increasing demand for protein therapeutics and targeted therapy, and growing preference for 3D cell cultures over 2D cell cultures, are driving the growth of the market over the forecast period.
• The optimization of the cell culture environment enables cells to grow, function, and survive in a realistic and representative manner. The surface coating of cell culture with protein involves coating the cell culture surface with extracellular matrix or protein components to improve the proliferation and adhesion of the cells in-vitro. Increasing stem cell research activities are expected to have a positive impact on the growth of the market.
• For instance, in June 2022, the Harvard Stem Cell Institute (HSCI) invited applications for seed grant funding for its 2022 cycle. The program's objective is to offer financial support for creative initiatives in the field of stem cell and regenerative biology to accelerate the development of new stem cell-based therapies or cures. As per the same above-mentioned source, the amounted award is USD 100,000 per project per year for up to two years. Thus the funding for the research activities increases the stem cell research activities that may drive the growth of the market over the forecast period.
• However, the high cost of cell culture protein surface coatings products and restrictions against the use of animal-source protein coating material may impede the growth of the market.

Cell Culture Protein Surface Coatings Market Trends

Microwell Plates Under Pre-coatings Expected to Grow Over the Forecast Period

• Microwell plates are also known as microplates or microtiter plates, or multiwells. The microplate has become a standard tool in analytical research and clinical diagnostic testing laboratories. Depending on the cell type, passage, origin, and makeup of the cell culture media, cells in culture adhere to the culture plates in various ways, even when they are grown on plastic made specifically for cell culture.
• The new advancements and approvals, and launches among the microwell plates drive the market growth over the study period. For instance, in April 2022, the Porvair Sciences Sero Krystal PDL family of coated microplates sets a new standard for repeatable cell culture, even with difficult cell types.
• The advanced microplate readers in the market increase the usage of microplates in biotechnology that, drive the market. For instance, in April 2022, Molecular Devices LLC launched its SpectraMax mini multi-mode microplate reader, a compact and economical solution designed to save researchers benchtop space and budget. Similarly, in February 2022, BMG LABTECH launched the VANTAstar microplate reader, further expanding its range of high-quality, made-in-Germany instruments. VANTAstar is a compact multi-mode microplate reader and is equipped with three features that enable an effortless detection setup and improve data quality.
• Hence, the above advancements and launches are expected to have a significant impact on the market through the segment.

North America Estimated to Hold the Largest Share in the Market

• North America is well known for its cell culture laboratories and funding for research in the healthcare domain. And it is expected to dominate the market over the forecast period. Every year in United States, the National Institutes of Health (NIH) heavily funds stem cell research. For research in cancer diseases and personalized medicine, the National Cancer Institute (NCI) allocates high funds to universities and companies collaborating with research centers.
• The American Cancer Society predicts that in 2022, there will be an estimated 1,918,030 new cases of cancer in United States. The rise in cancer cases increases the demand for targeted therapies which involve cell cultures and hence are expected to have a significant impact on the market over the forecast period. Additionally, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. Such factors boost the importance of cell culture activities.
• Additionally, the expansion of the major players in the market also has a significant impact on the market. For instance, in July 2021, Abcam, a global innovator in life sciences reagents and tools, opened a major new site in Waltham, Massachusetts, United States. The new facility is a central component of Abcam's growth in United States, reinforcing its commitment to support the research and biopharma sector.
• Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show considerable growth over the forecast period.

Cell Culture Protein Surface Coatings Market Competitive Analysis

The cell culture protein surface coating market is moderately fragmented and consists of several major players. The major market players are focusing on technological advancements in protein technology and cell culture techniques. Some of the major players in the market are Abcam PLC, Corning Incorporated, Greiner AG (Greiner Bio-One International GmbH), Merck KGaA, Promega Corporation, Sartorius AG, Qiagen NV, Viogene, and Thermo Fisher Scientific Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Stem Cell Research Activities
  • 4.2.2 Increasing Demand of Protein Therapeutics and Targeted Therapy
  • 4.2.3 Growing Preference for 3D Cell Cultures over 2D Cell Cultures
• 4.3 Market Restraints
  • 4.3.1 High Cost of Cell Culture Protein Surface Coatings Products
  • 4.3.2 Restriction Against Use of Animal Source Protein Coating Material
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

• 5.1 By Protein Source
  • 5.1.1 Animal-derived Protein
  • 5.1.2 Human-derived Protein
  • 5.1.3 Synthetic Protein
  • 5.1.4 Plant-derived Protein
• 5.2 By Type of Coating
  • 5.2.1 Self-coating
  • 5.2.2 Pre-coating
    • 5.2.2.1 Microwell Plates
    • 5.2.2.2 Petri Dish
    • 5.2.2.3 Flask
    • 5.2.2.4 Slides
    • 5.2.2.5 Other Types of Pre-coatings
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 France
    • 5.3.2.2 Germany
    • 5.3.2.3 United Kingsom
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Abcam PLC
  • 6.1.2 Corning Incorporated
  • 6.1.3 Greiner AG (Greiner Bio-One International GmbH)
  • 6.1.4 Merck KGaA
  • 6.1.5 Promega Corporation
  • 6.1.6 Qiagen NV
  • 6.1.7 Sartorius AG
  • 6.1.8 Thermo Fisher Scientific Inc.
  • 6.1.9 Viogene

7 MARKET OPPORTUNITIES AND FUTURE TRENDS